The present invention is directed to novel themisone derivative compounds th at have been modified to prevent the formation of the toxic metabolite, 2-pheny l- acrylamide. Compositions comprising such derivative compounds have activity as anesthetics and as neuroprotective agents.
NOVEL ORAL GENERAL ANESTHETICS AND METABOLITICALLY RESISTANTANTICONVULSANTS